Pfizer CEO Albert Bourla joins The Exchange to discuss new developments with his company’s Covid vaccine, one of the two mRNA vaccines approved for emergency use in the U.S. The company is reporting new data about waning immunity and protection…
Suzanne Judd, Ph.D., Epidemiologist at the University of Alabama at Birmingham School of Public Health, joins Yahoo Finance to discuss the latest on the coronavirus pandemic. #Pandemic #Coronavirus #Epidemiologist #Immunity Watch the 2021 Berkshire Hathaway Annual Shareholders Meeting on YouTube:…
#coronavirus #COVID19 #coronavirusvaccines Dr. Owais Durrani, Emergency Medicine Resident Physician at UT Health San Antonio, joins Yahoo Finance to discuss COVID-19 immunity and the potential need for booster shots. Watch the 2021 Berkshire Hathaway Annual Shareholders Meeting on YouTube: Subscribe…
#herdimmunity #COVID19 #coronavirus Yahoo Finance’s Kristin Myers spoke with Baylor College of Medicine Assistant Professor Dr.Cedric Dark about the coronavirus pandemic, herd immunity, and COVID-19 vaccinations. Watch the 2021 Berkshire Hathaway Annual Shareholders Meeting on YouTube: Subscribe to Yahoo Finance:…
#coronavirus #COVID19 #coronavirusvaccine The CEO of Pfizer has warned that a third COVID-19 vaccine dose will likely be necessary within 12 months. Get Us PPE Co-Founder and Harvard Medical School Professor Dr. Ali Raja joins Yahoo Finance’s Anjalee Khemlani and…
#herdimmunity #vaccinerollout #coronavirus Yahoo Finance’s Adam Shapiro and Seana Smith spoke with Dr. James McDeavitt, Senior Vice President and Dean of Clinical Affairs at Baylor College of Medicine about the rise in coronavirus cases, herd immunity, and vaccine rollout. Subscribe…
